Nisa Investment Advisors, LLC Vbi Vaccines Inc Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.38 - $22.5 $190 - $11,250	500 New	500 $0
Q2 2022 Aug 03, 2022	SELL	$0.66 - $1.81 $83,688 - $229,508	-126,800 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$1.27 - $2.47 $147,612 - $287,088	116,230 Added 1099.62%	126,800 $210,000
Q4 2021 Feb 03, 2022	SELL	$2.21 - $3.22 $221,950 - $323,384	-100,430 Reduced 90.48%	10,570 $18,000
Q4 2020 Jan 25, 2021	BUY	$2.15 - $3.5 $238,650 - $388,500	111,000 New	111,000 $305,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.